Yoshihiko Tasaki – InmunoES

A high eosinophil proportion increases the risk of skin-related adverse events induced by apalutamide in patients with prostate cancer

6 de October de 2025 by Yoshihiko Tasaki

BackgroundSkin-related adverse events (AEs) induced by apalutamide occur frequently in Japanese patients with prostate cancer. However, biomarkers for predicting these skin-related AEs have not yet been identified. Therefore, this study investigated wh…

Eosinophil is a predictor of severe immune-related adverse events induced by ipilimumab plus nivolumab therapy in patients with renal cell carcinoma: a retrospective multicenter cohort study

9 de January de 2025 by Yoshihiko Tasaki

IntroductionImmune-related adverse events (irAEs) induced by immune checkpoint inhibitors are difficult to predict and can lead to severe events. Although it is important to develop strategies for the early detection of severe irAEs, there is a lack of…